SCHEMBL3979356

SCHEMBL3979356

C[C@@](N)(I)c1ccc(Br)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.40
CA2 P00918 2/20 0.39
CA1 P00915 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 2/20 0.38
MAPK1 P28482 1/20 0.38
NOS1 P29475 2/20 0.33
TAAR1 Q96RJ0 2/20 0.32
OGG1 O15527 1/20 0.32
PDE2A O00408 1/20 0.32
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR2A P28223 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025732 1.00 CYP2A6 (0.40) CYP2A6CA2CA1CA5ACA9
SCHEMBL756324 0.79 PDE2A (0.50) CYP2A6CA2CA1CA5ACA9
SCHEMBL19997246 0.79 CYP2A6 (0.44) CYP2A6CA2CA1CA5ACA9
Iodide SCHEMBL25233569 0.77 PDE2A (0.48) CYP2A6CA2CA1CA5ACA9
SCHEMBL3661955 0.77 TSHR (0.55) CYP2A6CA2CA1CA5ACA9
Hydrochloric Acid SCHEMBL992228 0.77 PDE2A (0.48) CYP2A6CA2CA1CA5ACA9
SCHEMBL19981810 0.77 TSHR (0.55) CYP2A6CA2CA1CA5ACA9
SCHEMBL3980605 0.77 TSHR (0.55) CYP2A6CA2CA1CA5ACA9
SCHEMBL7944567 0.75 CYP2A6 (0.40) CYP2A6CA2CA1CA5ACA9
SCHEMBL1704452 0.75 KCNN4 (0.41) ALDH1A1MAPK1NOS1PDE2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009056993-A2 A PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-05-07 WO claimed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009056993-A2 A PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-05-07 WO disclosed